Aβ1-42 C-terminus fragment derived peptides prevent the self-assembly of the parent peptide

被引:8
作者
Bansal, Sunil [1 ]
Maurya, Indresh Kumar [2 ]
Shenmar, Kitika [1 ]
Yadav, Nitin [3 ]
Thota, Chaitanya Kumar [3 ]
Kumar, Vinod [4 ]
Tikoo, Kulbhushan [4 ]
Chauhan, Virander Singh [3 ]
Jain, Rahul [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res, Dept Med Chem, Sect 67, Sas Nagar 160062, Punjab, India
[2] Panjab Univ, Dept Microbial Biotechnol, Sect 14, Chandigarh 160014, India
[3] Int Ctr Genet Engn & Biotechnol, Aruna Asif Ali Marg, New Delhi 110067, India
[4] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Sect 67, Sas Nagar 160062, Punjab, India
来源
RSC ADVANCES | 2017年 / 7卷 / 07期
关键词
BETA-SHEET BREAKERS; ALZHEIMERS-DISEASE; AMYLOID-BETA; INHIBITORS; TRIAL; AGGREGATION; TOXICITY; STRATEGY; THERAPY; REDUCE;
D O I
10.1039/c6ra26295c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In an attempt to design Ab aggregation inhibitors to combat Alzheimer's disease, herein we report a full peptide scan performed on a pentapeptide fragment (A beta(38-42)) derived from the C-terminus of A beta(1-42) peptide. More than thirty new peptides were synthesized and tested for their inhibition activity towards Ab self-assembly. In the cell viability assay, when co-incubated with Ab, three peptides were found to completely prevent the toxicity induced by Ab aggregation. Most active pentapeptides were also studied by ThT fluorescence assay and the results were well correlated to the MTT study. The inhibition potential of a pentapeptide (15) was further confirmed by CD spectroscopy and transmission electron microscopy.
引用
收藏
页码:4167 / 4173
页数:7
相关论文
共 30 条
[1]  
Alzheimer A, 1995, Clin Anat, V8, P429
[2]  
[Anonymous], 2004, SAFETY STUDY PPI 101
[3]  
[Anonymous], 2013, EFF SAF TRIAL MK 893
[4]  
[Anonymous], 2014, World Alzheimer Report 2014
[5]   C-Terminal Fragment, Aβ32-37, Analogues Protect Against Aβ Aggregation-Induced Toxicity [J].
Bansal, Sunil ;
Maurya, Indresh Kumar ;
Yadav, Nitin ;
Thota, Chaitanya Kumar ;
Kumar, Vinod ;
Tikoo, Kulbhushan ;
Chauhan, Virander Singh ;
Jain, Rahul .
ACS CHEMICAL NEUROSCIENCE, 2016, 7 (05) :615-623
[6]  
Bieler S, 2004, CURR DRUG TARGETS, V5, P553
[7]   Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis [J].
Bloom, George S. .
JAMA NEUROLOGY, 2014, 71 (04) :505-508
[8]   Poly-N-methylated Amyloid β-Peptide (Aβ) C-Terminal Fragments Reduce Aβ Toxicity in Vitro and in Drosophila melanogaster [J].
Bose, Partha Pratim ;
Chatterjee, Urmimala ;
Nerelius, Charlotte ;
Govender, Thavendran ;
Norstrom, Thomas ;
Gogoll, Adolf ;
Sandegren, Anna ;
Gothelid, Emmanuelle ;
Johansson, Jan ;
Arvidsson, Per I. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (24) :8002-8009
[9]   A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease [J].
Doody, Rachelle S. ;
Raman, Rema ;
Farlow, Martin ;
Iwatsubo, Takeshi ;
Vellas, Bruno ;
Joffe, Steven ;
Kieburtz, Karl ;
He, Feng ;
Sun, Xiaoying ;
Thomas, Ronald G. ;
Aisen, Paul S. ;
Siemers, Eric ;
Sethuraman, Gopalan ;
Mohs, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (04) :341-350
[10]   New strategy for the generation of specific D-peptide amyloid inhibitors [J].
Esteras-Chopo, Alexandra ;
Pastor, M. Teresa ;
Serrano, Luis ;
de la Paz, Manuela Lopez .
JOURNAL OF MOLECULAR BIOLOGY, 2008, 377 (05) :1372-1381